These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12742967)

  • 1. Percutaneous treatment of saphenous vein bypass graft obstructions: a continuing obstinate problem.
    de Feyter PJ
    Circulation; 2003 May; 107(18):2284-6. PubMed ID: 12742967
    [No Abstract]   [Full Text] [Related]  

  • 2. Totally occluded saphenous vein graft recanalization: a dangerous option.
    Londero HF
    Catheter Cardiovasc Interv; 2003 Oct; 60(2):218-20. PubMed ID: 14517928
    [No Abstract]   [Full Text] [Related]  

  • 3. Percutaneous intervention in saphenous vein bypass graft disease: case against the use of drug-eluting stents.
    Bansal D; Sachdeva R; Mehta JL
    J Am Coll Cardiol; 2008 Mar; 51(9):970-1; author reply 971-2. PubMed ID: 18308169
    [No Abstract]   [Full Text] [Related]  

  • 4. Coronary angioplasty and new devices in patients with prior coronary artery bypass graft surgery.
    Ribeiro PA
    Rev Port Cardiol; 1999 Feb; 18 Suppl 1():I105-11. PubMed ID: 10191682
    [No Abstract]   [Full Text] [Related]  

  • 5. Contemporary management of vein graft disease.
    Hermiller J
    J Invasive Cardiol; 2005 Aug; 17(8):399-400. PubMed ID: 16079442
    [No Abstract]   [Full Text] [Related]  

  • 6. Beyond embolic protection for saphenous vein graft disease.
    Satler LF
    Catheter Cardiovasc Interv; 2008 Nov; 72(5):641-2. PubMed ID: 18949778
    [No Abstract]   [Full Text] [Related]  

  • 7. Saphenous vein graft disease.
    Peykar S; Angiolillo DJ; Bass TA; Costa MA
    Minerva Cardioangiol; 2004 Oct; 52(5):379-90. PubMed ID: 15514573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTCA of degenerated vein grafts: experience of two periods (1992-93 and 1996-97) in 780 patients.
    Reifart N; Störger H; Schwarz F; Rabe A
    Indian Heart J; 1998 Oct; 50 Suppl 1():62-6. PubMed ID: 9824909
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimal therapy for degenerated saphenous vein graft disease.
    Kramer B
    J Invasive Cardiol; 1995; 7 Suppl D():14D-20D. PubMed ID: 10155126
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic total occlusion treatment in post-CABG patients: saphenous vein graft versus native vessel recanalization-long-term follow-up in the drug-eluting stent era.
    Meliga E; García-García HM; Kukreja N; Daemen J; Tanimoto S; Ramcharitar S; van Mieghem CA; Sianos G; van der Ent M; van der Giessen WJ; de Feyter P; van Domburg R; Serruys PW
    Catheter Cardiovasc Interv; 2007 Jul; 70(1):21-5. PubMed ID: 17584913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time from coronary artery bypass surgery does not affect outcome in patients treated with primary angioplasty for acute saphenous vein graft occlusion.
    van der Schaaf RJ; Vis MM; Sjauw KD; Koch KT; Baan J; Tijssen JG; de Winter RJ; Piek JJ; Henriques JP
    Heart; 2007 Mar; 93(3):381-2. PubMed ID: 17322522
    [No Abstract]   [Full Text] [Related]  

  • 12. The clinical impact of atherosclerotic saphenous vein to coronary artery bypass grafts.
    Lytle BW
    Semin Thorac Cardiovasc Surg; 1994 Apr; 6(2):81-6. PubMed ID: 8025142
    [No Abstract]   [Full Text] [Related]  

  • 13. Embolic protection devices in saphenous vein graft interventions.
    Cragun DT; Heuser RR
    J Interv Cardiol; 2006 Dec; 19(6):525-9. PubMed ID: 17107367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approach to the patient with prior bypass surgery.
    Nguyen T; Pham L; Cheem TH; Douglas JS; Hermiller J; Grines C
    J Interv Cardiol; 2004 Oct; 17(5):339-46. PubMed ID: 15491339
    [No Abstract]   [Full Text] [Related]  

  • 15. The "Proxis-Tornus" technique for a difficult-to-cross calcified saphenous vein graft lesion.
    Brilakis ES; Banerjee S
    J Invasive Cardiol; 2008 Sep; 20(9):E258-61. PubMed ID: 18762683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial infarction in saphenous percutaneous intervention: are we really doing our best?
    Lozano I; Rondan J; Avanzas P
    Am Heart J; 2009 Sep; 158(3):e39; author reply e41. PubMed ID: 19699850
    [No Abstract]   [Full Text] [Related]  

  • 17. The unrelenting challenge of vein graft disease.
    Hermiller JB
    J Invasive Cardiol; 2010 Jun; 22(6):258-9. PubMed ID: 20516503
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment alternatives for chronically occluded saphenous vein grafts.
    Heuser RR
    J Invasive Cardiol; 1995 May; 7(4):94-6. PubMed ID: 10158110
    [No Abstract]   [Full Text] [Related]  

  • 19. Alteration of "jetlike" laminar flow after percutaneous transluminal angioplasty of saphenous vein bypass graft stenosis.
    Kern MJ; Gibson P; Vandormael M
    Cathet Cardiovasc Diagn; 1986; 12(3):165-8. PubMed ID: 2942261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous treatment of diseased saphenous vein grafts: current state-of-the-art and future directions.
    Vermeersch P; Agostoni P
    Minerva Cardioangiol; 2007 Oct; 55(5):637-46. PubMed ID: 17912167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.